CONCEPTUS, INC.(NASDAQ: CPTS) is scheduled to report earnings on Tuesday (2/23/2010) with analyst looking for $0.22
Conceptus, Inc. designs and develops minimally invasive devices for
reproductive medical applications. Conceptus'' focus is to develop its
STOP non-surgical permanent contraception device for women. STOP is
designed to be a less-invasive, safer, and less costly alternative to
surgical sterilization, more commonly known as tubal ligation. The STOP
device is designed to achieve contraception by elliciting a tissue
response which occludes the fallopian tubes.
Fundamental Report :
- Recently one or more analyst upgraded the stock. Positive
- The earnings are growing from last one year including recent quarter. Positive
- The company recorded sales growth in last quarter . Positive
Performance Report :
- The stock is gaining momentum as compare to its peers : Positive
- The stock is gaining momentum as compare to its industry : Positive
Technical Report :
- The stock is trading between support and resistance : Neutral.
- The moving average is steadily improving : Very Positive.
- MACD points to bullish movement : Positive.
- ADX points to uptrending movement : Positive.
- The Bollinger Bands are very narrow : Neutral.
- The RSI shows bearish movement : Very Negative.
- The Chaikin Money Flow Index Signal bullish movement : Positive.
- The Slow Stochastic signal downward movement : Very Negative.
- The average volume is rising confirming the trend.
Key Ratios :
- P/E Ratio: 85.680
- PEG Ratio: 1.220
Earnings Performance :
- EPS Growth in Last Quarter: 1,300.00 %
- EPS Growth in Last Year: 140.00 %
- Sales Growth in Last Quarter: 3.62 %
- Sales Growth in Last Year: 28.53 %
Earnings Estimates
- Current Estimates: $0.22
- Number of Estimates: 8
- High Estimate: $0.28
- Low Estimate: $0.20
- Last Year EPS: $0.17
- Percentage Growth: 29.00 %
Charts:
Technical Chart:
Sector Chart:
